May 20, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

ASCO 2019 schedule
ASCO ATTENDEES: This schedule is being provided so you are able to plan to see posters and presentations on NRG Oncology research.


Register today to have your fee waived!

We hope you can join us for the NRG Oncology Semiannual Meeting, July 18-20, 2019, at the Philadelphia Marriott Downtown in Philadelphia, PA. Pre-Registration for this meeting is complimentary for all NRG members who pre-register by the deadline of June 25, 2019. We kindly ask that everyone please pre-register for this meeting before the deadline. Onsite registration will incur a $100 fee. 

Registration and meeting information is available on the NRG Oncology website.


Meeting Highlights

  • Patient Reported Outcomes: Upping the game for PRO methods and design in clinical trials - NRG Oncology will be holding a workshop at the NRG Semiannual Meeting related to improving statistical methods to meet study goals, analyzing longitudinal PRO data as well as a panel discussion with NCORP PIs. This session will be held on Thursday, July 18, 2019 from 1-5pm and will be open to all attendees. More information on the session and agenda will be released soon.
  • Symposium: Thursday, July 18 -  8am-3pm Read more
  • Scientific Session: Friday, July 19 -  8-10am
  • Health Disparities Workshop Special Session: Sexual and Gender Minority Related Activities at the NIH - Friday, July 19 – 10-11:30am Read more
  • Social Media Workshop: Friday, July 19 - 11:30am-12:30pm 

Social Media Workshop 1-on-1's at #NRG19

Are you ready to get started on Twitter?  Let our social media experts show you how simple it is to set up a new account or make your existing account more engaging. At #NRG19, we have scheduled two Social Media 1-on-1 Workshops where our Twitter experts will be on hand to show you the how-to's of Twitter. If you are interested in learning more about tweeting, retweeting, hashtags, following, and more, stop by during one of the following sessions and bring your smartphone &/or laptop. No previous social media experience required! Friday, July 19, 12:30-1pm and Saturday, July 20, 10-11am.



NRG-GU003: Amendment 1; Version date: April 26, 2019 (Posted on CTSU)


NRG-GY006: Amendment 4; Version date: February 1, 2019 (posted on CTSU)


NRG GU003: Data Collection Summary Form has been revised and posted on CTSU.  Refer to the revised version, dated May 13, 2019.



NRG-BR003: E-mail Blast (posted on CTSU)


NSABP B-43: Call for submission of data and supporting documentation (posted on CTSU)



NRG-GI002: E-mail Blast (posted on CTSU)



NRG-GY009: Block Submission Reminder memo (posted on CTSU)


Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more


Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more



NRG-LU003: The Spanish-translated consent form and CIRB approval of the form are available on CTSU.


5. Children’s Oncology Group Protocol AGCT1531: “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial.

Enrollment credited to NRG Oncology will count towards membership requirements.



The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for Wednesday, June 12.


Safety updates and IB notices have been issued for the following studies:





















*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( ). Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.


Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).


Dr. Wolmark to receive Gianni Bonadonna Breast Cancer Award at ASCO's 2019 Annual Meeting

Norman Wolmark, MD, Chairman of the NSABP Foundation and one of the three NRG Oncology group chairs, will receive the 2019 Gianni Bonadonna Breast Cancer Award at the annual ASCO meeting, May 31-June 4 in Chicago. As a recipient of this award, Dr. Wolmark will deliver his address, "The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer: A 60-year Odyssey" on Saturday, June 1, 2019 (4:45-5:30pm CT). The Gianni Bonadonna Breast Cancer Lecture Award recognizes an active clinical researcher with a distinguished record of accomplishments in advancing breast cancer research. For more information about the award and past recipients, click here.


The NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, Serum Bank at Baylor, and McKesson Clinical Research Services will be closed on Monday, May 27, 2019 in observance of the Memorial Day holiday. Please note: the Philadelphia West Operations office and SDMC Philadelphia office will close at noon, and the Philadelphia East Operations office will close at 12:30 on Friday, May 24.  For more information about the holiday closures, please see the memo that is posted on the CTSU website or NRG Oncology website under "News."

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.



Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM. Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. J Clin Oncol. 2019 May 10;37(14):1159-1168. doi: 10.1200/JCO.18.02158. Epub 2019 Mar 12. PubMed PMID: 30860948.   Read more


Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American Brachytherapy Society (ABS); Jun 13-15, 2019; Miami, FL

American Society of Clinical Oncology (ASCO); May 31 - Jun 4, 2019; Chicago, IL

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-5, 2019; Cleveland, OH

Western Association of Gynecologic Oncologists (WAGO);Jun 12-15, 2019; Huntington Beach, CA


Upcoming Abstract Submission Deadlines

European Society for Medical Oncology (ESMO); Sep 27-Oct 1, 2019; Barcelona, Spain; LBA Aug 21, 2019 9:00 pm CEST

San Antonio Breast Cancer Symposium (SABCS); Dec 10-14, 2019; San Antonio, TX; due to publications committee Jun 24, 2019; meeting submission deadline Jul 8, 2019

Society for Neuro-Oncology (SNO); Nov 20-24, 2019; Phoenix, AZ; due to publications committee May 27, 2019; meeting submission deadline June 10, 2019





NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from to
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address | Forward Email | Report Abuse